“Marc Beer: Raising Funds to Create more Treatment Options “

Posted on January 14, 2019

Marc Beer is the founder of Renovia Inc., a medical startup that aims to provide treatment for women who are suffering from diseases that are mostly found in females. The creation of the startup started after Marc Beer realized the need for more effective treatment that would enable women in the society to face their hardest battles, and through Renovia Inc., he was able to deliver what he wanted to do – to help the women and give them a chance to live normal lives. Renovia Inc. currently focuses on the creation of a treatment for the pelvic floor disorders, which was diagnosed in more than 250 million individuals around the world. Women have a higher risk of developing the disorder after they gave birth, and many medical institutions around the world are working together to solve the problem.

 

One of the best solutions presented to help those who are diagnosed with the pelvic floor disorder would be the creation of a medicinal drug that could correct their condition. Leva was the most recent product from Renovia Inc. which aims to treat those who are suffering from pelvic floor disorder. Marc Beer is enthusiastic about the project, saying that 250 million people will benefit from the treatment that they have developed. Leva has been subjected to FDA inspection and testing back in the early parts of 2018, and by April, the primary tests have already concluded, and the drug was permitted to be sold on the American market.

 

Another thing that Marc Beer contributed would be the establishment of funding for the company, and he invited some of the biggest capital providers in the country to help him reach his target. Throughout the whole fundraising program, Marc Beer was able to raise $42 million, coming from different sources. Longwood Fund gave the highest amount during the fundraising program, stating that they share the same passion for helping those who are in need. Longwood Fund stated that they are rooting for the success of Renovia Inc. towards their goal of eradicating conditions affecting women around the world. Through the funding that they have provided, they are hoping that more treatment options will be developed to save the lives of many women. Learn more: https://www.crunchbase.com/person/marc-beer

 

Four more products are scheduled to be released later this year, and Marc Beer said that without the funding from investors and financial institutions, the research would not push through and they would never have the chance to see the treatments being developed. Marc Beer has more than two decades of experience working in the medical industry. He focused on the field of pharmaceutical and biotechnology, and he is trying to put up the things that he learned in the past to support the medical revolution that aims to help those who are suffering from diseases that should have been eradicated long ago.

 

Renovia CEO Marc Beer Successfully Raises $42.3 Million in Funds for Womens Healthcare

Posted on October 20, 2018

Co-founder, Chairman and CEO Marc Beer of Renovia celebrates the successful completion of $42.3 million in funding that shall pave a way for the research and diagnostics in women’s healthcare. Marc Beer who is renowned in his field of commercialization and development catering to pharmaceuticals, therapeutics, devices and diagnostics for over twenty-five years is thrilled to announce the successful completion of the Series B financing. The funding will mainly help Renovia continue with its research and development for Women’s health, focusing on pelvic floor disorders and the breakthrough research and development in the said area. Renovia was established in 2016. Learn more: https://renoviainc.com/

 

Pelvic floor disorder is known as the prolapse or the collapse of the urethra, bladder, uterus, small intestine, rectum and even the vagina due to the weakened state of ligaments caused by an injury or injuries in the connective tissues. To date, Renovia stands as one of the leaders, since 2016, in its determination to focus clinical developmental research for women with pelvic floor disorder.

 

Marc Beer recently commented on the approval and completion of the 43.2 million funds that he is thrilled to feel the support of the world’s leading healthcare investors who envision the same goals as he does. A vision, he says, to help treat and better diagnose the millions of women who share in his pursuit and dreams of living a better-quality life regardless of being affected by pelvic floor disorder.

 

Renovia is the creator of “Leva,” a digitalized pelvic healthcare system. The “Leva” kit helps women affected with pelvic floor disorder to digitally strengthen and train their pelvic floor muscles within the comfort of their own home. The Leva kit is FDA approved and created for the rehabilitation of the weakened pelvic muscles. It includes an EmbaGYN Pelvic Floor Exercise and the leva Pelvic Digital Health System. The product is both used to help and distinguish the pelvic floor disorders to better diagnose and strengthen the muscles.

 

Renovia’s success in acquiring the 42.3 Million in financial funding shall help in its clinical development to update and create new and improved digital health kits for women with the disorder. The goal of the company is to enhance current version of the kit and continue with the research in the field of women’s health at the same time create affordable products for women and healthcare providers. The products created are digitally enhanced to be easily used by women on their mobile phones. Renovia’s pipeline is set to include further research and development within the next few years since approval and completion of the funding.